Skip to main content
TipRanks
Go Ultimate75% OFF

Ilan Hadar Insider Profile

4 Followers

Ilan Hadar, Chairman & CEO, Director at Silexion Therapeutics, holds 16.55K shares in Silexion Therapeutics (Ticker: SLXN), holds 77.35K shares in Yarrow Bioscience (Ticker: YARW), holds 130.58K shares in Foamix Pharma (Ticker: FOMX).

Ilan Hadar's Trading History

SLXN
Silexion Therapeutics
Jun 08, 2026Chairman & CEO, DirectorUninformative Buy―$21.68K
YARW
Yarrow Bioscience
Mar 11, 2020CFO and Country ManagerUninformative Buy―$997.83K
FOMX
Foamix Pharma
Feb 24, 2020―Uninformative Buy―$390.43K

You May Also Like

Ilan Hadar insider profile FAQ

What stocks does Ilan Hadar hold?
Ilan Hadar holds: SLXN, FOMX, YARW stocks.
What is Ilan Hadar's role in Silexion Therapeutics?
Ilan Hadar's role in Silexion Therapeutics is Chairman & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.